Clinical Trial Update: Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Photodynamic Therapy with Metvix cream in organ transplant recipients with non-melanoma skin cancers completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Basal Cell Carcinoma
• Bowen Disease
• Squamous Cell Carcinoma
• Warts

Drugs mentioned

• Metvix (methyl aminolevulinate)

Snippet

Sponsor: Galderma R&D | Conditions: Actinic Keratosis, Warts | Phase 3 | Status: COMPLETED | Results posted: 2025-04-18